Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PNA-1 by ProNeurogen for Traumatic Brain Injury: Likelihood of Approval
PNA-1 is under clinical development by ProNeurogen and currently in Phase II for Traumatic Brain Injury. According to GlobalData, Phase...